Article Details

$200M investment to advance clinical programs for Ambrx

Retrieved on: 2020-11-23 23:03:45

Tags for this article:

Click the tags to see associated articles and topics

$200M investment to advance clinical programs for Ambrx. View article details on hiswai:

Excerpt

The San Diego-based <b>biopharma</b> firm has several oncology therapies in development and has partnered in the past with the likes of Astellas, BeiGene ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo